AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9403265
Drug: Povidone-iodine sugar
RxNorm normalized name: Povidone-Iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Povidone-iodine sugar ointment (P-1, P-2)
Trial: 30290905
Drug: Thalidomide (200-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide (200-400 mg, orally on days 1-28) during induction and maintenance therapy.
Trial: 30290905
Drug: Thalidomide maintenance
RxNorm normalized name: Thalidomide
DrugBank: Thalidomide (DB01041)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Thalidomide maintenance therapy (50 mg, orally, daily).
Trial: 30290905
Drug: Interferon alfa
RxNorm normalized name: Interferon alfa
DrugBank: Interferon alfa (DB05258)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa (3 × 10^6 international units, subcutaneously, three times weekly) during maintenance therapy.
Trial: 22801271
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation (national made atorvastatin)
Trial: 22801271
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation (imported atorvastatin)
Trial: 15735110
Drug: Daily multiple
RxNorm normalized name: Daily Multiple Vitamins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily multiple micronutrient supplement (DMM)
Trial: 15735110
Drug: Daily placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily placebo supplement (P)
Trial: 15735110
Drug: Multiple micronutrient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple micronutrient supplement 1 day of the week and placebo on other days (WMM)
Trial: 15735110
Drug: Daily iron
RxNorm normalized name: Walgreens Multivitamin One Daily Iron-Free Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily iron supplement (DI)
Trial: 8916595
Drug: Pilocarpine 1%
RxNorm normalized name: PILOCARPINE 1% SOLN,OPH
DrugBank: Pilocarpine (DB01085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pilocarpine 1% and Clonidine 0.125% combination
Trial: 28319550
Drug: Basal infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal infusion (8 mL/h)
Trial: 28319550
Drug: Bolus doses
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus doses (24 mL every 3 hours for a total of 2 bolus doses)
Trial: 24047421
Drug: Anastrozole 1
RxNorm normalized name: anastrozole 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole 1 mg/day (N=25)
Trial: 24047421
Drug: Tamoxifen 20
RxNorm normalized name: tamoxifen 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 20 mg/day (N=24)
Trial: 21861972
Drug: Selective laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective laser trabeculoplasty (performed a mean of 8.3 ± 4.1 days before injection)
Trial: 21861972
Drug: Intravitreal triamcinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal triamcinolone acetonide injection (control group)
Trial: 9928687
Drug: Ketorolac (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac (60 mg intramuscular injection)
Trial: 9928687
Drug: Meperidine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine (100 to 150 mg intramuscular injection based on weight)
Trial: 7233551
Drug: Niridazole (7-day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niridazole (7-day treatment)
Trial: 7233551
Drug: Praziquantel (1-day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel (1-day treatment, 2 x 30 mg per kg)
Trial: 30085011
Drug: Injection drug
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection drug use during one month prior to recruitment
Trial: 28452603
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy during surgery (Group M)
Trial: 28452603
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy (Group M)
Trial: 12562741
Drug: Dialectical behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialectical behaviour therapy (DBT) for 12 months
Trial: 16903592
Drug: Rolling needle
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rolling needle therapy at the Urinary Bladder Channel line 1 and 2 and the Governor Vessel for 4 weeks
Trial: 16903592
Drug: Clonopin 4-6
RxNorm normalized name: Klonopin
DrugBank: Clonazepam (DB01068)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonopin 4-6 mg for 4 weeks
Trial: 16903592
Drug: Rolling needle
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rolling needle therapy after 3 months follow-up
Trial: 14684393
Drug: Orlistat (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat (120 mg 3 times daily)
Trial: 11339779
Drug: Spinal anesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anesthesia (SA) with 50 mg of 1% lidocaine
Trial: 10423596
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg ebastine after overnight fast
Trial: 10423596
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg ebastine after low-fat breakfast
Trial: 10423596
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg ebastine after high-fat breakfast
Trial: 10423596
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg ebastine after overnight fast
Trial: 10423596
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg ebastine after high-fat breakfast
Trial: 3295883
Drug: Adenosine (0.104
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine (0.104 +/- 0.024 mg/kg)
Trial: 3295883
Drug: Verapamil (8.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (8.4 +/- 3.4 mg IV)
Trial: 29073351
Drug: Belimumab at
RxNorm normalized name: Belimumab
DrugBank: Belimumab (DB08879)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Belimumab at 10 mg/kg intravenously
Trial: 23899530
Drug: Sunitinib at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunitinib at 37.5mg daily until progression or a maximum of 6 months (arm B)
Trial: 20839434
Drug: Dexamethasone (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (20 mg) intravenously injected before 1 hour of cement injection
Trial: 20839434
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (2 mL) intravenously injected
Trial: 20839434
Drug: Dexamethasone (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (20 mg) intravenously injected
Trial: 15837829
Drug: Red wine
RxNorm normalized name: Red wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red wine (375 mL; 39 grams alcohol)
Trial: 15837829
Drug: Beer (1125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beer (1125 mL; 41 grams alcohol)
Trial: 15837829
Drug: De-alcoholized red
RxNorm normalized name: sangre de grado
FDA approved: no
EMA approved: no
PMDA approved: no
Description: De-alcoholized red wine (375 mL)
Trial: 10467610
Drug: TPN as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPN as adjunct of medical therapy (Group I)
Trial: 7592151
Drug: Stimulus-choice procedure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulus-choice procedure with two treatments based on Premack's principle
Trial: 6794419
Drug: Metoprolol Durules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol Durules administered once daily at a daily dosage of 200 mg
Trial: 6794419
Drug: Metoprolol tablets
RxNorm normalized name: metoprolol Oral Tablet
DrugBank: Metoprolol (DB00264)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoprolol tablets administered twice daily at a daily dosage of 200 mg
Trial: 29709606
Drug: Non-surgical periodontal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-surgical periodontal therapy (NSPT) combined with antimicrobial photodynamic therapy (aPDT)
Trial: 22437556
Drug: Rice-based lunch
RxNorm normalized name: Rice
DrugBank: Rice (DB10563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rice-based lunch meals fortified with low-iron (6.25 mg) micronutrients
Trial: 22437556
Drug: Rice-based lunch
RxNorm normalized name: Rice
DrugBank: Rice (DB10563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rice-based lunch meals fortified with high-iron (12.5 mg) micronutrients
Trial: 11155731
Drug: 7 day
RxNorm normalized name: ZonaCort 7 Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 day treatment
Trial: 11155731
Drug: 14 day
RxNorm normalized name: Ponvory 14 Day Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14 day treatment
Trial: 8684102
Drug: Atovaquone 1000
RxNorm normalized name: Atovaquone
DrugBank: Atovaquone (DB01117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atovaquone 1000 mg daily and proguanil 400 mg daily for 3 days
Trial: 8684102
Drug: Amodiaquine 600
RxNorm normalized name: Amodiaquine
DrugBank: Amodiaquine (DB00613)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amodiaquine 600 mg on admission, 600 mg 24 h later, and 300 mg after a further 24 h
Trial: 14621737
Drug: Oral nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral nifedipine (group B)
Trial: 14621737
Drug: Low-dose CyA
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose CyA plus azathioprine (group C)
Trial: 3970747
Drug: Antibiotics (penicillinase-resistant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics (penicillinase-resistant penicillin or erythromycin)
Trial: 3970747
Drug: Penicillinase-resistant antibiotic
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillinase-resistant antibiotic
Trial: 25863559
Drug: Ledipasvir (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ledipasvir (90 mg) and sofosbuvir (400 mg)
Trial: 25863559
Drug: Ledipasvir (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ledipasvir (90 mg) and sofosbuvir (400 mg) plus ribavirin
Trial: 19040034
Drug: MF59-adjuvanted influenza
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF59-adjuvanted influenza subunit vaccine (FLUAD)
Trial: 19040034
Drug: Conventional non-adjuvanted
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional non-adjuvanted influenza subunit vaccine (Agrippal)
Trial: 10475285
Drug: Amiodarone (3.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone (3.4 g over 5 days or 2.2 g over 24 hours)
Trial: 2771867
Drug: flunitrazepam 1
RxNorm normalized name: flunitrazepam 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: flunitrazepam 1 mg
Trial: 8091361
Drug: triazolam 0.25
RxNorm normalized name: triazolam 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: triazolam 0.25 mg
Trial: 6147843
Drug: lormetazepam 1
RxNorm normalized name: lormetazepam 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lormetazepam 1 mg
Trial: 29790581
Drug: PUR0200 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PUR0200 3 μg
Trial: 29790581
Drug: PUR0200 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PUR0200 6 μg
Trial: 29790581
Drug: PUR0200 9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PUR0200 9 μg
Trial: 29790581
Drug: Tiotropium HH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium HH 18 μg
Trial: 8187256
Drug: Oral ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ketamine 5.0 mg.kg‐1
Trial: 989091
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous heparin sodium therapy
Trial: 989091
Drug: Intermittent (four‐hourly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent (four‐hourly bolus) heparin therapy
Trial: 29283470
Drug: REMD‐477 (70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: REMD‐477 (70 mg dose)
Trial: 27331913
Drug: Caffeine-polyphenol supplement
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine-polyphenol supplement
Trial: 24269575
Drug: Duloxetine (combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine (combined serotonin-norepinephrine reuptake inhibitor)
Trial: 10877010
Drug: Caffeine (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (single oral dose)
Trial: 21061756
Drug: Methylaminolevulinate (MAL)
RxNorm normalized name: maleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylaminolevulinate (MAL) 80 mg/g without occlusion followed by 25 J/cm2 red light exposure
Trial: 21061756
Drug: Methylaminolevulinate (MAL)
RxNorm normalized name: maleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylaminolevulinate (MAL) 80 mg/g with occlusion followed by 25 J/cm2 red light exposure
Trial: 21061756
Drug: Methylaminolevulinate (MAL)
RxNorm normalized name: maleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylaminolevulinate (MAL) 80 mg/g without occlusion followed by 37 J/cm2 red light exposure
Trial: 21061756
Drug: Methylaminolevulinate (MAL)
RxNorm normalized name: maleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylaminolevulinate (MAL) 80 mg/g with occlusion followed by 37 J/cm2 red light exposure
Trial: 17426414
Drug: Antidepressant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant treatment (paroxetine or clomipramine)
Trial: 9580313
Drug: 0.9 MU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9 MU of rIL‐2 subcutaneously administered daily for 8 weeks
Trial: 9580313
Drug: 1.8 MU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.8 MU of rIL‐2 subcutaneously administered daily for 8 weeks
Trial: 9580313
Drug: 3.6 MU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.6 MU of rIL‐2 subcutaneously administered daily for 8 weeks
Trial: 23537017
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (1000 mg total)
Trial: 18281352
Drug: Cumulative weekly
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Cumulative weekly breastfeeding duration by 13 weeks
Trial: 15271868
Drug: Half-dose triptorelin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half-dose triptorelin (1.87 mg)
Trial: 15271868
Drug: Full-dose triptorelin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-dose triptorelin (3.75 mg)
Trial: 10858349
Drug: Itraconazole oral
RxNorm normalized name: itraconazole Oral Tablet
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Itraconazole oral solution (2.5 mg/kg twice a day)
Trial: 10858349
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B capsules (500 mg orally four times a day)
Trial: 20142307
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of sleep deprivation and morphine
Trial: 20142307
Drug: Buprenorphine on
RxNorm normalized name: Buprenorphine only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine on dosing day with sleep deprivation
Trial: 20142307
Drug: Alternate-day buprenorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternate-day buprenorphine dosing
Trial: 18664888
Drug: Psychosocial treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychosocial treatments for PTSD
Trial: 18664888
Drug: Psychosocial treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychosocial treatments for PTSD targeting combat-related trauma
Trial: 16599101
Drug: Zinc sulphate
RxNorm normalized name: Zinc sulphate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulphate tablet (20 mg)
Trial: 12166540
Drug: Budesonide/formoterol 160/4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol 160/4.5 microg, two inhalations twice daily (n=390)
Trial: 12166540
Drug: Budesonide plus
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide plus formoterol administered via separate inhalers (n=190)
Trial: 10604851
Drug: Air inhalation
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air inhalation (control)
Trial: 1714669
Drug: Bonnecor (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bonnecor (2 x 0.1 to 1 x 0.3 mg/kg body weight)
Trial: 27918733
Drug: Basic information
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic information given verbally with details of operative procedures and recovery, and by watching a movie on single implant surgery (movie group)
Trial: 23958023
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (FO) supplement (200 g/d)
Trial: 23958023
Drug: Microalgae (MA)
RxNorm normalized name: Mielim Y Mas
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Microalgae (MA) supplement (200 g/d)
Trial: 23958023
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no marine oil supplement)
Trial: 19116800
Drug: Insomnia treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insomnia treatment study volunteers (n = 120)
Trial: 19116800
Drug: Clinical patients
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical patients seeking treatment (n = 106)
Trial: 17263835
Drug: Levofloxacin 500
RxNorm normalized name: levofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin 500 mg once-daily (n = 122)
Trial: 17263835
Drug: Ciprofloxacin 500
RxNorm normalized name: ciprofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 500 mg twice-daily plus phenethicillin 250 mg four-times-daily (n = 120)
Trial: 8500785
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg metoclopramide
Trial: 8500785
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg metoclopramide
Trial: 8500785
Drug: 0.4 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg/kg metoclopramide
Trial: 7481852
Drug: Combination regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination regimens
Trial: 2553879
Drug: Initial treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial treatment with MVP
Trial: 31550354
Drug: High-dose (HD)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose (HD) trivalent inactivated vaccine
Trial: 31550354
Drug: Standard-dose (SD)
RxNorm normalized name: Alphanine SD
DrugBank: Coagulation Factor IX Human (DB13152)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose (SD) trivalent inactivated vaccine
Trial: 23126307
Drug: Aspirin initiated
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin initiated before 16 weeks of gestation (from meta-analysis)
Trial: 19427269
Drug: High-dose ascorbic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose ascorbic acid (about 30 mg/kg/day)
Trial: 15541413
Drug: 3 mL
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mL of Gynol II gel
Trial: 15541413
Drug: 5 mL
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL of Gynol II gel
Trial: 11185653
Drug: Alcohol consumption
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol consumption (mean 81.8 g/d, range 40-150 g/d)
Trial: 9293612
Drug: Valaciclovir (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valaciclovir (1000 mg, twice daily)
Trial: 9293612
Drug: Acyclovir (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir (200 mg, 5 times daily)
Trial: 28478107
Drug: Individualized endobronchial
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized endobronchial photodynamic therapy (PDT) under fluorescence control, violet light 408nm, diagnostic light.
Trial: 26541878
Drug: Loperamide-simeticone chewable
RxNorm normalized name: loperamide / simethicone Chewable Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loperamide-simeticone chewable tablet
Trial: 20928835
Drug: Oral zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral zinc gluconate plus corticosteroid treatment
Trial: 18602474
Drug: MK (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK (1.0 mg morphine + 5 mg ketamine/bolus)
Trial: 18602474
Drug: MO (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MO (1.5 mg morphine/bolus)
Trial: 17140533
Drug: Carisolv group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carisolv group (excavation with a chemical solution and special blunt hand instruments)
Trial: 17140533
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of residual caries and cervical gaps
Trial: 14523778
Drug: Indinavir-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indinavir-based therapy (with or without other antiretroviral drugs)